Pilot Grants Available – Apply by Sept 15, 2021
CDC, PerkinElmer Readying Molecular SMA Tests as Stakeholders Push for Nationwide Newborn Screening
Parents’ Experiences 12 Years after Newborn Screening for Genetic Susceptibility to Type 1 Diabetes and Their Attitudes to Whole-Genome Sequencing in Newborns
The FDA and 23andMe: Overreaching and overreacting?
Prenatal Identification of Increased Risk for Schizophrenia
Genetic Information Not Always Benign
Does Genetic Testing Pose Psychosocial Risks?
Columbia University to Explore Impact of Genetic Information about Autism on Families, Individuals
Our Uncertain Eugenics: Population and Proband Dilemmas in Non-Invasive Prenatal Screening
Save the Dates! 2021-2022 Seminars Announcement
Psychological Research in the Context of Psychiatric Genetics and Genomics
Do Genetic Findings Impact Perceptions of Responsibility? A Public Virtual Symposium
Issue Briefs & Commentaries »
The FDA and 23andMe: Overreaching and overreacting?
Prenatal Identification of Increased Risk for Schizophrenia
Genetic Information Not Always Benign
Press Releases »
Does Genetic Testing Pose Psychosocial Risks?
Columbia University to Explore Impact of Genetic Information about Autism on Families, Individuals
Events »
Our Uncertain Eugenics: Population and Proband Dilemmas in Non-Invasive Prenatal Screening
Save the Dates! 2021-2022 Seminars Announcement
Psychological Research in the Context of Psychiatric Genetics and Genomics
Do Genetic Findings Impact Perceptions of Responsibility? A Public Virtual Symposium
Click here to subscribe to our newsletter!
This center is a Center for Excellence in ELSI Research funded by a grant from the National Institutes of Health #RM1HG007257-06